Labopharm Appoints Sylvain Guenette as CFO
Labopharm, a Canadian pharmaceutical firm, has appointed Sylvain Guénette as chief financial officer (CFO). Guénette, a chartered accountant, joined Labopharm as controller in 2002 and was most recently vice president and corporate controller. Prior to joining Labopharm, Guénette was corporate controller at Les Systèmes Proxima Ltée and director of finance and operations at the Montreal office of Nurun. Guenette has also held various finance and accounting positions within the Quebecor Group.
On 14 March, 2011, Mark D’Souza, Lambopharm’s then CFO, was named as new president and chief executive officer (CEO). D’Souza replaced James Howard-Tripp, who resigned from Labopharm’s board of directors.